Pompe Disease Clinical Trials | Amicus Therapeutics
← Amicus Clinical Trials

Pompe Disease Clinical Trials

ATB200/AT2221: Phase 1/2 Safety Study (ATB200-02 Study)

More information: www.clinicaltrials.gov: NCT02675465